In recent years, various nanotechnology platforms in the area of medical biology, including
both diagnostics and therapy, have gained remarkable attention. Moreover, research and …

Cancer is a highly complex disease to understand, because it entails multiple cellular
physiological systems. The most common cancer treatments are restricted to chemotherapy …

Affibody molecules are a class of engineered affinity proteins with proven potential for
therapeutic, diagnostic and biotechnological applications. Affibody molecules are small (6.5 …

In recent years new nucleic acid and protein‐based combinatorial molecules have attracted
the attention of researchers working in various areas of science, ranging from medicine to …

Non-immunoglobulin (non-Ig) scaffolds are, in contrast to antibodies, small single-domain
proteins that require no post-translational modification, often lack disulfide bonds, and can …

The overall objective of liposomal drug delivery is to selectively target drug delivery to
diseased tissue, while minimizing drug delivery to critical normal tissues. The purpose of this …

Nanoparticles (NPs) are novel drug delivery systems that have been attracting more and
more attention in recent years, and have been used for the treatment of cancer, infection …

A great deal of effort has been made over the years to develop liposomes that have targeting
vectors (oligosaccharides, peptides, proteins and vitamins) attached to the bilayer surface …

In this Review, we attempt to offer a thorough description of all of the chemical components
and the rationale behind the design of temperature-sensitive vesicle systems, as well as the …

Using nanoparticles for the delivery of small molecules in anticancer therapy is a rapidly
growing area of research. The advantages of using nanoparticles for drug delivery include …